San Millán Iñigo, Bing Kristen, Brill Carrie, Hill John C, Miller Larry E
University of Colorado School of Medicine, Aurora, CO, USA.
Miller Scientific Consulting, Inc, Arden, NC, USA.
Open Access J Sports Med. 2013 Oct 16;4:221-7. doi: 10.2147/OAJSM.S51956. eCollection 2013.
The purpose of this paper was to assess the feasibility of Micro-Mobile Compression® (MMC) on lactate clearance following exhaustive exercise and on subsequent exercise performance.
Elite male cyclists were randomized to MMC (n = 8) or passive recovery (control, n = 8). MMC is incorporated into a sandal that intermittently compresses the venous plexus during non-weight bearing to augment venous return. On day 1, subjects performed a graded exercise test on a cycle ergometer followed by 60 minutes of seated recovery, with or without MMC. Blood lactate concentration ([La(-)]) was measured during exercise and recovery. Subjects returned home for 3 more hours of seated recovery, with or without MMC. On days 2 and 3, subjects exercised to exhaustion in a fixed-load cycle ergometer test at 85% peak power and then repeated the day 1 post-exercise recovery procedures. Lactate clearance data after the time to exhaustion tests on days 2 and 3 were averaged to adjust for interday variation.
On the day after MMC or control recovery, mean time to exhaustion was 15% longer (mean difference, 2.1 minutes) in the MMC group (P = 0.30). The standardized mean difference of MMC for time to exhaustion was 0.55, defined as a moderate treatment effect. Following the graded exercise test, area under the 60-minute lactate curve was nonsignificantly lower with MMC (3.2 ± 0.4 millimolar [mM]) versus control (3.5 ± 0.4 mM, P = 0.10) and times from end of exercise to 4mM and 2mM were 2.1 minutes (P = 0.58) and 7.2 minutes (P = 0.12) shorter, although neither achieved statistical significance. Following time to exhaustion testing, the area under the 60-minute lactate curve was lower with MMC (3.2 ± 0.2 mM) versus control (3.5 ± 0.2 mM, P = 0.02) and times from end of exercise to 4mM and 2mM were 4.4 minutes (P = 0.02) and 7.6 minutes (P < 0.01) faster. The standardized mean difference of MMC on most lactate clearance parameters was >0.8, defined as a large treatment effect.
MMC yields large treatment effects on lactate clearance following high-intensity exercise and moderate treatment effects on subsequent exercise performance in elite male cyclists.
本文旨在评估微移动压缩(MMC)对力竭运动后乳酸清除率以及后续运动表现的可行性。
将精英男性自行车运动员随机分为MMC组(n = 8)或被动恢复组(对照组,n = 8)。MMC被整合到一种凉鞋中,在非负重状态下间歇性压缩静脉丛以增加静脉回流。在第1天,受试者在自行车测力计上进行分级运动测试,随后进行60分钟的坐位恢复,恢复过程中有无MMC干预。在运动和恢复过程中测量血乳酸浓度([La⁻])。受试者回家后再进行另外3小时的坐位恢复,恢复过程中有无MMC干预。在第2天和第3天,受试者在固定负荷的自行车测力计测试中以85%的峰值功率运动至力竭,然后重复第1天运动后的恢复程序。将第2天和第3天力竭测试后的乳酸清除率数据进行平均,以调整日间差异。
在MMC或对照组恢复后的第二天,MMC组的平均力竭时间长15%(平均差异为2.1分钟)(P = 0.30)。MMC对力竭时间的标准化平均差异为0.55,定义为中等治疗效果。在分级运动测试后,MMC组(3.